AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Jul 18, 2011
30016_dirs_2011-07-18_70a9e881-2d9f-47c1-86d4-8dfc422b0c93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-07-15
Reporting Person: DEADY CONAN R (CORP VP, GENERAL COUNSEL & SEC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-07-15 | Common Stock | M | 16029 | $41.935 | Acquired | 35376 | Direct |
| 2011-07-15 | Common Stock | M | 3609 | $53.31 | Acquired | 38985 | Direct |
| 2011-07-15 | Common Stock | M | 362 | $56.95 | Acquired | 39347 | Direct |
| 2011-07-15 | Common Stock | S | 20000 | $78.3722 | Disposed | 19347 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-07-15 | Non-Qualified Stock Option (right to buy) | $41.9350 | M | 16029 | Disposed | 2014-02-13 | Common Stock (16029) | Direct |
| 2011-07-15 | Non-Qualified Stock Option (right to buy) | $53.31 | M | 3609 | Disposed | 2017-02-13 | Common Stock (3609) | Direct |
| 2011-07-15 | Non-Qualified Stock Option (right to buy) | $56.95 | M | 362 | Disposed | 2015-02-13 | Common Stock (362) | Direct |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/09/2011.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $78.3874 to $78.08, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, 3,870 shares on 02/14/2011 and the remaining 1,704 shares on 02/14/2012.
F4: Grant of options to buy shares of common stock becomes exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014 and the remaining 1,733 shares on 02/14/2015.
F5: Grant of options to buy shares of common stock becomes exercisable as to 3,449 shares on 02/14/2009 and 02/14/2010, 3,448 shares on 02/14/2011 and 02/14/2012, and the remaining 1,693 shares on 02/14/2013.